Ignite Creation Date:
2024-05-05 @ 11:26 AM
Last Modification Date:
2024-10-26 @ 9:07 AM
Study NCT ID:
NCT00043537
Status:
COMPLETED
Last Update Posted:
2013-08-01
First Post:
2002-08-09
Brief Title:
Treatment of Childhood Social Phobia
Sponsor:
University of Central Florida
Organization:
University of Central Florida
Study Overview
Official Title:
Treatment of Childhood Social Phobia
Status:
COMPLETED
Status Verified Date:
2013-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This 4-year study will compare the long-term effectiveness of behavioral treatment fluoxetine Prozac and placebo for treatment of social phobia in children and adolescents
Detailed Description:
Social phobia affects 3-5 percent of children and prevalence rises with age Youth with social phobia fear many activities that are part of everyday life and suffer from problems such as headaches or stomachaches panic avoidance general anxiety depression loneliness and a very restricted range of social relationships Recent findings indicate a new psychosocial treatment called Social Effectiveness Therapy for Children SET-C is effective in treating children ages 8-11 resulting in reduced emotional distress and improved social functioning Treatment effects have been maintained for up to 6 months This study will examine SET-C in children ages 8-15 Because available data suggest that the drug fluoxetine is a promising treatment SET-C will be compared to fluoxetine in this trial Durability of treatment will be monitored over a 1-year follow-up period
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| R01MH053703 | NIH | None | httpsreporternihgovquickSearchR01MH053703 |